Thursday, May 14, 2026
Latest News:

iShares U.S. Healthcare ETF

Business

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Business Investor 6 min read 33 Views 0 Comments ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the

Read More
Business

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win

Business Investor 1 min read 56 Views 0 Comments ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,

Read More
Business

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Business Investor 3 min read 64 Views 0 Comments ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake |

Read More
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one

Business Investor 1 min read 77 Views 0 Comments ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

We respect your privacy and take protecting it seriously